Data-driven Communications

The Challenge

Our client was interested in expanding their company’s awareness in the pharmaceutical industry and making their name well known as a leading healthcare PR company.

In the healthcare space, plenty of research and thought leadership had been published about Covid, so our client needed to find a unique story that stood out. In the spring of 2021, Americans were finally getting their Covid vaccinations and started developing brand attitudes that had never been seen before in the pharmaceutical industry.

Our approach

On behalf of our client, we designed and fielded a robust survey to 1,000 ethnically diverse Americans to discover how the distribution of the vaccines changed consumer awareness and consideration of pharmaceutical brands.

This in-depth quantitative study uncovered how Americans view big pharma brands post-pandemic, whether or not there is a preferred “vaccine brand” and how the customer decision process will change in regard to future healthcare decision making.

The outcome

We were able to provide our client with clear-cut data which they presented at high-level industry conferences and other media events.

Our client’s thought leadership piece was also picked up by reputable news sources such as Scientific American , NASDAQ, CBS News and many others resulting in millions of views in earned publicity for the company.